Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : ckbsupport@jax.org
NCT ID | NCT03439462 |
Title | ABI-009 (Nab-rapamycin) in Combination With FOLFOX and Bevacizumab as First-line Therapy in Patients With Advanced or Metastatic Colorectal Cancer |
Recruitment | Active, not recruiting |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | Aadi, LLC |
Indications | |
Therapies |
Bevacizumab + Fluorouracil + Leucovorin + Nab-rapamycin + Oxaliplatin |
Age Groups: | senior | adult |
Covered Countries | USA |